ASTH
HealthcareAstrana Health, Inc.
$24.02+0.77 (+3.31%)
Prev Close
$23.25
Open
$23.91
High
$24.85
Low
$23.70
Volume
310.8K
Market Cap
$1.24B
P/E
120.10
Div Yield
—
Over the past 12 months, insider activity at Astrana Health, Inc. (ASTH) has been exclusively selling, with 0 insider purchases totaling $0.00 and 17 insider sales totaling $3.59M. The most recent insider transaction was by Kumar Dinesh M. (Chief Medical Officer), who sold $292.2K worth of shares on Jan 23, 2026. Astrana Health, Inc. operates in the Healthcare sector, within the Medical - Care Facilities industry, with a market cap of $1.24B.
Buys (12M)
0
$0.00
Sells (12M)
17
$3.59M
Net Activity
Net Seller
$3.59M
Active Insiders
7
last 12 mo
ASTH Price Chart
ASTH Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 23, 2026↗ | Kumar Dinesh M. | Chief Medical Officer | Sell | 10,759 | $27.16 | $292.2K | 0 |
| Jan 13, 2026↗ | Schmidt David | Director | Sell | 4,269 | $27.12 | $115.8K | 0 |
| Jan 1, 2026↗ | Kumar Dinesh M. | Chief Medical Officer | Sell | 5,102 | $24.81 | $126.6K | 0 |
| Dec 8, 2025↗ | Lam Thomas S. | Director | Sell | 25,866 | $22.00 | $569.1K | 0 |
| Nov 3, 2025↗ | Marsh Linda | Director | Sell | 11,033 | $32.99 | $364.0K | 0 |
| Oct 2, 2025↗ | Basho Chandan | COO and CFO | Sell | 1,979 | $27.77 | $55.0K | 0 |
| Sep 15, 2025↗ | Kitayama Mitchell W | Director | Sell | 13,214 | $30.23 | $399.5K | 0 |
| Sep 5, 2025↗ | Basho Chandan | COO and CFO | Sell | 1,694 | $29.70 | $50.3K | 0 |
| Sep 5, 2025↗ | Kumar Dinesh M. | Chief Medical Officer | Sell | 1,694 | $29.70 | $50.3K | 0 |
| Sep 2, 2025↗ | Schmidt David | Director | Sell | 20,000 | $27.76 | $555.2K | 0 |
| Aug 13, 2025↗ | Chiang John | Director | Sell | 12,284 | $29.63 | $364.0K | 0 |
| Jul 1, 2025↗ | Kumar Dinesh M. | Chief Medical Officer | Sell | 6,831 | $25.06 | $171.2K | 0 |
| Jun 4, 2025↗ | Kumar Dinesh M. | Chief Medical Officer | Sell | 1,656 | $25.06 | $41.5K | 0 |
| May 16, 2025↗ | Basho Chandan | COO and CFO | Sell | 10,035 | $27.18 | $272.8K | 0 |
| Apr 29, 2025↗ | Kumar Dinesh M. | Chief Medical Officer | Sell | 828 | $31.15 | $25.8K | 0 |
| Apr 14, 2025↗ | Basho Chandan | COO and CFO | Sell | 2,683 | $34.05 | $91.4K | 0 |
| Apr 2, 2025↗ | Basho Chandan | COO and CFO | Sell | 1,394 | $30.02 | $41.8K | 0 |
| Mar 5, 2025↗ | Kumar Dinesh M. | Chief Medical Officer | Sell | 7,866 | $27.19 | $213.9K | 0 |
| Mar 5, 2025↗ | Lam Thomas S. | Director | Sell | 9,235 | $27.19 | $251.1K | 0 |
| Mar 5, 2025↗ | Sim Brandon | CEO and President | Sell | 105,795 | $27.19 | $2.88M | 0 |
| Jan 23, 2025↗ | Kumar Dinesh M. | Chief Medical Officer | Sell | 7,210 | $37.96 | $273.7K | 0 |
| Jan 1, 2025↗ | Kumar Dinesh M. | Chief Medical Officer | Sell | 967 | $31.53 | $30.5K | 0 |
| Dec 10, 2024↗ | Kitayama Mitchell W | Director | Sell | 5,100 | $43.09 | $219.8K | 0 |
| Nov 30, 2024↗ | Vong John | Chief Accounting Officer | Sell | 134 | $43.25 | $5.8K | 0 |
| Nov 22, 2024↗ | Kitayama Mitchell W | Director | Sell | 1,490 | $42.11 | $62.7K | 0 |
| Nov 19, 2024↗ | Chiang John | Director | Sell | 681 | $40.93 | $27.9K | 0 |
| Nov 12, 2024↗ | Vong John | Chief Accounting Officer | Sell | 636 | $42.91 | $27.3K | 0 |
| Nov 8, 2024↗ | Basho Chandan | COO and CFO | Sell | 691 | $46.96 | $32.4K | 0 |
| Oct 2, 2024↗ | Sim Brandon | CEO and President | Sell | 2,626 | $57.87 | $152.0K | 0 |
| Sep 10, 2024↗ | Kitayama Mitchell W | Director | Sell | 3,522 | $47.93 | $168.8K | 0 |
| Sep 10, 2024↗ | Marsh Linda | Director | Sell | 3,522 | $47.93 | $168.8K | 0 |
| Sep 9, 2024↗ | Chiang John | Director | Sell | 3,565 | $47.35 | $168.8K | 0 |
| Sep 9, 2024↗ | Lam Thomas S. | Director | Sell | 11,046 | $47.35 | $523.0K | 0 |
| Aug 14, 2024↗ | Schmidt David | Director | Sell | 14,409 | $49.76 | $717.0K | 0 |
| Aug 1, 2024↗ | Kumar Dinesh M. | See remarks | Sell | 794 | $51.57 | $40.9K | 0 |
| Aug 1, 2024↗ | Vong John | Chief Accounting Officer | Sell | 67 | $51.57 | $3.5K | 0 |
| Jul 11, 2024↗ | Vong John | Chief Accounting Officer | Sell | 336 | $45.00 | $15.1K | 0 |
| May 16, 2024↗ | Basho Chandan | COO and CFO | Sell | 7,051 | $41.13 | $290.0K | 0 |
| May 12, 2024↗ | Vong John | Chief Accounting Officer | Sell | 636 | $38.89 | $24.7K | 0 |
| Mar 29, 2024↗ | Basho Chandan | COO and CFO | Sell | 14,500 | $41.29 | $598.7K | 0 |
| Mar 29, 2024↗ | Sim Brandon | CEO and President | Sell | 37,957 | $41.99 | $1.59M | 0 |
| Dec 6, 2023↗ | Kitayama Mitchell W | Director | Sell | 7,500 | $33.49 | $251.2K | 0 |
| Dec 6, 2023↗ | Schmidt David | Director | Sell | 7,500 | $33.49 | $251.2K | 0 |
| Nov 30, 2023↗ | Vong John | Chief Accounting Officer | Sell | 65 | $33.23 | $2.2K | 0 |
| May 16, 2023↗ | Vong John | Chief Accounting Officer | Sell | 325 | $32.07 | $10.4K | 0 |
| Apr 14, 2023↗ | Basho Chandan | See Remarks | Sell | 2,494 | $39.06 | $97.4K | 0 |
| Mar 14, 2023↗ | Marsh Linda | Director | Sell | 270,081 | $35.32 | $9.54M | 0 |
| Jun 17, 2022↗ | Marsh Linda | Director | Sell | 250,000 | $37.00 | $9.25M | 0 |
| Mar 31, 2022↗ | Chin Eric | Chief Financial Officer | Sell | 469 | $48.47 | $22.7K | 0 |
| Mar 31, 2022↗ | Young Albert WaiChow | Chief Administrative Officer | Sell | 256 | $48.47 | $12.4K | 0 |
| Feb 3, 2022↗ | Chin Eric | Chief Financial Officer | Sell | 2,802 | $50.71 | $142.1K | 0 |
| Aug 17, 2021↗ | Schmidt David | Director | Sell | 40,000 | $73.67 | $2.95M | 0 |
| Jun 15, 2021↗ | Young Albert WaiChow | Chief Administrative Officer | Sell | 5,000 | $48.58 | $242.9K | 0 |
| May 31, 2021↗ | Sim Brandon | See Remarks | Sell | 5,426 | $34.88 | $189.3K | 0 |
| May 13, 2021↗ | Sim Brandon | See Remarks | Buy | 1,000 | $31.40 | $31.4K | 0 |
| Apr 28, 2021↗ | Vazquez Adrian | Chief Medical Officer | Sell | 100,000 | $24.50 | $2.45M | 0 |
| Mar 31, 2021↗ | Chin Eric | Chief Financial Officer | Sell | 555 | $27.09 | $15.0K | 0 |
| Mar 31, 2021↗ | Young Albert WaiChow | Chief Administrative Officer | Sell | 256 | $27.09 | $6.9K | 0 |
ASTH Insider Buying Activity
The following table shows recent insider purchases of Astrana Health, Inc. (ASTH) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 13, 2021↗ | Sim Brandon | See Remarks | Buy | 1,000 | $31.40 | $31.4K | 0 |
ASTH Insider Selling Activity
The following table shows recent insider sales of Astrana Health, Inc. (ASTH) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 23, 2026↗ | Kumar Dinesh M. | Chief Medical Officer | Sell | 10,759 | $27.16 | $292.2K | 0 |
| Jan 13, 2026↗ | Schmidt David | Director | Sell | 4,269 | $27.12 | $115.8K | 0 |
| Jan 1, 2026↗ | Kumar Dinesh M. | Chief Medical Officer | Sell | 5,102 | $24.81 | $126.6K | 0 |
| Dec 8, 2025↗ | Lam Thomas S. | Director | Sell | 25,866 | $22.00 | $569.1K | 0 |
| Nov 3, 2025↗ | Marsh Linda | Director | Sell | 11,033 | $32.99 | $364.0K | 0 |
| Oct 2, 2025↗ | Basho Chandan | COO and CFO | Sell | 1,979 | $27.77 | $55.0K | 0 |
| Sep 15, 2025↗ | Kitayama Mitchell W | Director | Sell | 13,214 | $30.23 | $399.5K | 0 |
| Sep 5, 2025↗ | Basho Chandan | COO and CFO | Sell | 1,694 | $29.70 | $50.3K | 0 |
| Sep 5, 2025↗ | Kumar Dinesh M. | Chief Medical Officer | Sell | 1,694 | $29.70 | $50.3K | 0 |
| Sep 2, 2025↗ | Schmidt David | Director | Sell | 20,000 | $27.76 | $555.2K | 0 |
| Aug 13, 2025↗ | Chiang John | Director | Sell | 12,284 | $29.63 | $364.0K | 0 |
| Jul 1, 2025↗ | Kumar Dinesh M. | Chief Medical Officer | Sell | 6,831 | $25.06 | $171.2K | 0 |
| Jun 4, 2025↗ | Kumar Dinesh M. | Chief Medical Officer | Sell | 1,656 | $25.06 | $41.5K | 0 |
| May 16, 2025↗ | Basho Chandan | COO and CFO | Sell | 10,035 | $27.18 | $272.8K | 0 |
| Apr 29, 2025↗ | Kumar Dinesh M. | Chief Medical Officer | Sell | 828 | $31.15 | $25.8K | 0 |
| Apr 14, 2025↗ | Basho Chandan | COO and CFO | Sell | 2,683 | $34.05 | $91.4K | 0 |
| Apr 2, 2025↗ | Basho Chandan | COO and CFO | Sell | 1,394 | $30.02 | $41.8K | 0 |
| Mar 5, 2025↗ | Kumar Dinesh M. | Chief Medical Officer | Sell | 7,866 | $27.19 | $213.9K | 0 |
| Mar 5, 2025↗ | Lam Thomas S. | Director | Sell | 9,235 | $27.19 | $251.1K | 0 |
| Mar 5, 2025↗ | Sim Brandon | CEO and President | Sell | 105,795 | $27.19 | $2.88M | 0 |
| Jan 23, 2025↗ | Kumar Dinesh M. | Chief Medical Officer | Sell | 7,210 | $37.96 | $273.7K | 0 |
| Jan 1, 2025↗ | Kumar Dinesh M. | Chief Medical Officer | Sell | 967 | $31.53 | $30.5K | 0 |
| Dec 10, 2024↗ | Kitayama Mitchell W | Director | Sell | 5,100 | $43.09 | $219.8K | 0 |
| Nov 30, 2024↗ | Vong John | Chief Accounting Officer | Sell | 134 | $43.25 | $5.8K | 0 |
| Nov 22, 2024↗ | Kitayama Mitchell W | Director | Sell | 1,490 | $42.11 | $62.7K | 0 |
| Nov 19, 2024↗ | Chiang John | Director | Sell | 681 | $40.93 | $27.9K | 0 |
| Nov 12, 2024↗ | Vong John | Chief Accounting Officer | Sell | 636 | $42.91 | $27.3K | 0 |
| Nov 8, 2024↗ | Basho Chandan | COO and CFO | Sell | 691 | $46.96 | $32.4K | 0 |
| Oct 2, 2024↗ | Sim Brandon | CEO and President | Sell | 2,626 | $57.87 | $152.0K | 0 |
| Sep 10, 2024↗ | Kitayama Mitchell W | Director | Sell | 3,522 | $47.93 | $168.8K | 0 |
| Sep 10, 2024↗ | Marsh Linda | Director | Sell | 3,522 | $47.93 | $168.8K | 0 |
| Sep 9, 2024↗ | Chiang John | Director | Sell | 3,565 | $47.35 | $168.8K | 0 |
| Sep 9, 2024↗ | Lam Thomas S. | Director | Sell | 11,046 | $47.35 | $523.0K | 0 |
| Aug 14, 2024↗ | Schmidt David | Director | Sell | 14,409 | $49.76 | $717.0K | 0 |
| Aug 1, 2024↗ | Kumar Dinesh M. | See remarks | Sell | 794 | $51.57 | $40.9K | 0 |
| Aug 1, 2024↗ | Vong John | Chief Accounting Officer | Sell | 67 | $51.57 | $3.5K | 0 |
| Jul 11, 2024↗ | Vong John | Chief Accounting Officer | Sell | 336 | $45.00 | $15.1K | 0 |
| May 16, 2024↗ | Basho Chandan | COO and CFO | Sell | 7,051 | $41.13 | $290.0K | 0 |
| May 12, 2024↗ | Vong John | Chief Accounting Officer | Sell | 636 | $38.89 | $24.7K | 0 |
| Mar 29, 2024↗ | Basho Chandan | COO and CFO | Sell | 14,500 | $41.29 | $598.7K | 0 |
| Mar 29, 2024↗ | Sim Brandon | CEO and President | Sell | 37,957 | $41.99 | $1.59M | 0 |
| Dec 6, 2023↗ | Kitayama Mitchell W | Director | Sell | 7,500 | $33.49 | $251.2K | 0 |
| Dec 6, 2023↗ | Schmidt David | Director | Sell | 7,500 | $33.49 | $251.2K | 0 |
| Nov 30, 2023↗ | Vong John | Chief Accounting Officer | Sell | 65 | $33.23 | $2.2K | 0 |
| May 16, 2023↗ | Vong John | Chief Accounting Officer | Sell | 325 | $32.07 | $10.4K | 0 |
| Apr 14, 2023↗ | Basho Chandan | See Remarks | Sell | 2,494 | $39.06 | $97.4K | 0 |
| Mar 14, 2023↗ | Marsh Linda | Director | Sell | 270,081 | $35.32 | $9.54M | 0 |
| Jun 17, 2022↗ | Marsh Linda | Director | Sell | 250,000 | $37.00 | $9.25M | 0 |
| Mar 31, 2022↗ | Chin Eric | Chief Financial Officer | Sell | 469 | $48.47 | $22.7K | 0 |
| Mar 31, 2022↗ | Young Albert WaiChow | Chief Administrative Officer | Sell | 256 | $48.47 | $12.4K | 0 |
| Feb 3, 2022↗ | Chin Eric | Chief Financial Officer | Sell | 2,802 | $50.71 | $142.1K | 0 |
| Aug 17, 2021↗ | Schmidt David | Director | Sell | 40,000 | $73.67 | $2.95M | 0 |
| Jun 15, 2021↗ | Young Albert WaiChow | Chief Administrative Officer | Sell | 5,000 | $48.58 | $242.9K | 0 |
| May 31, 2021↗ | Sim Brandon | See Remarks | Sell | 5,426 | $34.88 | $189.3K | 0 |
| Apr 28, 2021↗ | Vazquez Adrian | Chief Medical Officer | Sell | 100,000 | $24.50 | $2.45M | 0 |
| Mar 31, 2021↗ | Chin Eric | Chief Financial Officer | Sell | 555 | $27.09 | $15.0K | 0 |
| Mar 31, 2021↗ | Young Albert WaiChow | Chief Administrative Officer | Sell | 256 | $27.09 | $6.9K | 0 |
ASTH Insiders
Similar Stocks to ASTH
HCA
HCA Healthcare, Inc.
$534.18+0.30%
$119.10B
THC
Tenet Healthcare Corporation
$227.63+0.97%
$20.01B
UHS
Universal Health Services, Inc.
$192.42+0.78%
$12.23B
ENSG
The Ensign Group, Inc.
$209.71+0.41%
$12.19B
SOLV
Solventum Corporation
$66.76+0.60%
$11.58B
EHC
Encompass Health Corporation
$99.87-0.43%
$10.75B
DVA
DaVita Inc.
$150.75-1.51%
$10.10B
CHE
Chemed Corporation
$400.77+0.31%
$5.66B